))
This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Welcome to The Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma, Biotech and Medtech.
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
…
continue reading
News and Analysis of the Biotech and Pharma Industry for Investors and Executives.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
…
continue reading
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
…
continue reading
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
…
continue reading
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
…
continue reading
Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
…
continue reading
Seeking Alpha's investing experts provide deep dive stock analysis and topical takes on the market. Transcripts: seekingalpha.com/author/investing-experts-podcast
…
continue reading
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
…
continue reading
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
…
continue reading
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO with episodes launching weekly on Tuesday's. 🎧 Stay in the Loop! For the latest news and updates, visit our website: https://vial.com Follow us on social media for real-time insights: Twitter: https://twitter.com/VialTrials LinkedIn: https://www.linkedin.com/company/vialtrials
…
continue reading
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
…
continue reading
Join Hercules Capital in conversations with today’s top CEOs, CFOs, and investors in venture and private equity-backed companies. Learn about their strategies for financing rapid growth and scaling their businesses, as well as their unique interests and life stories that have shaped their paths to success.
…
continue reading
1
Pfizer's Q3 Success and Biopharma Updates: A Daily Dose of Pharma and Biotech News
0:54
0:54
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
0:54
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Pfizer exceeded Wall Street's expectations in the third quarter, reporting higher revenue and adjusted profit amid pressure from activist investor Starboard Value. CEO Albert Bourla received a much-needed victory as the …
…
continue reading
1
Just the Facts: St George Mining in MoU to fast-track Araxá Niobium-REE Project
1:29
1:29
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:29
Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from St George Mining Ltd (ASX:SGQ).The company has signed a Memorandum of Understanding (MoU) with the Minas Gerais State Economic Development Department and Invest Minas. The agreement prioritises regulatory support for St George's Araxá Niobium-Rare Earth Elements Project in…
…
continue reading
1
Just the Facts: Orthocell raises $17 million for US launch of Remplir and global expansion
1:32
1:32
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:32
Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Orthocell Ltd (ASX:OCC, OTC:ORHHF).The company has raised A$17 million to accelerate the US launch of its Remplir™ collagen wrap for peripheral nerve repair.Funds will also support global expansion for both Remplir™ and Striate+™, a resorbable collagen membrane for dental …
…
continue reading
1
Caprice Resources raises $2.5 million to boost Murchison Gold Projects
6:37
6:37
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
6:37
Caprice Resources Ltd (ASX:CPR) CEO Luke Cox talked with Proactive’s Tylah Tully about the company’s recent $2.5 million capital raise.The funding, completed through a placement with Canaccord, is allocated for advancing gold projects in the Murchison region of Western Australia.Focusing on high-grade, strategic targets, Cox highlighted key explora…
…
continue reading
1
Pharma and Biotech Daily: Eli Lilly Stock Drops, Biogen Exceeds Expectations, and More Updates
0:45
0:45
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
0:45
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Eli Lilly experienced lower-than-expected sales for its weight loss and diabetes drugs in the third quarter, causing its stock to drop by over 13%. Biogen, on the other hand, exceeded expectations for its Alzheimer's drug …
…
continue reading
1
Firebird Metals and CSU to advance LMFP technology in China
5:20
5:20
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:20
Firebird Metals Ltd (ASX:FRB, OTC:FRBMF) managing director Peter Allen sits down with Proactive’s Jonathan Jackson after the company formalised a strategic partnership with Central South University (CSU) in Hunan, China, aimed at developing a processing method for lithium manganese iron phosphate (LMFP) as a cathode active material (CAM). This coll…
…
continue reading
1
Just the Facts: Strickland Metals confirms thick, high-grade Rogozna intersections
1:35
1:35
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:35
Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Strickland Metals Ltd (ASX:STK).The company has received another thick, high-grade intersection from ongoing drilling at the Medenovac Prospect, part of its Rogozna Gold and Base Metals Project in Serbia.Recent diamond drilling revealed 43.4 metres at 4.6 g/t gold equivale…
…
continue reading
1
Gold Hydrogen confirms rare Helium-3 discovery at Ramsay
5:18
5:18
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:18
Gold Hydrogen Ltd (ASX:GHY) managing director Neil McDonald joins Proactive’s Tylah Tully to discuss the company’s latest discovery.In collaboration with Oxford University, it has identified Helium-3, a rare isotope essential for nuclear fusion, at its Ramsay Project in South Australia.Helium-3, which is valued at more than $2,500 per litre, holds …
…
continue reading
1
Tiziana Life Sciences' Semaglutide Combo Shows Potential in Obesity-Related Liver Inflammation
4:53
4:53
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:53
Tiziana Life Sciences CEO Ivor Elrifi joined Steve Darling from Proactive to share news the company has announced positive research findings showing the anti-inflammatory potential of the company’s nasal anti-CD3 antibody, foralumab, when used in combination with semaglutide, a GLP-1 agonist marketed as Ozempic and Wegovy. The study, conducted by D…
…
continue reading
1
Ananda Developments advances clinical trials, names Scientific Advisory Board
4:06
4:06
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:06
Ananda Developments Finance Director Jeremy Sturgess-Smith joined Steve Darling from Proactive to share some of the key milestones achieved by the company in its interim results for February 1, 2024, to July 31, 2024. During this period, Ananda has advanced its patent-pending MRX1 CBD formulation in two fully funded Phase II trials for chemotherapy…
…
continue reading
1
Inside the Latest Advances in Hearing Tech ft. Envoy Medical CEO Brent Lucas
20:23
20:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
20:23
In this episode, Ayesha spoke with Brent Lucas, CEO of Envoy Medical. Envoy Medical is a medical device company focused on providing cutting-edge technologies across the hearing loss spectrum. According to the National Institute of Deafness and Other Communication Disorders, 13 percent of people in the US 12 years of age and older have hearing loss…
…
continue reading
1
Tolu Minerals Secures A$26.7M to Boost Tolukuma Gold Mine Exploration and Redevelopment
5:51
5:51
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:51
Tolu Minerals CEO Iain Macpherson joined Steve Darling from Proactive to share news that the company has successfully raised A$26.7 million through a heavily backed placement, with strong demand from both new and existing institutional and sophisticated investors, domestically and internationally. This funding will enable Tolu Minerals to advance e…
…
continue reading
1
Helix Exploration begins drilling at Rudyard project in Montana, targeting key helium reservoirs
3:18
3:18
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:18
Helix Exploration Chairman David Minchin joined Steve Darling from Proactive to announce the start of drilling at the Rudyard Project in Montana with the Darwin #1 well. This well aims to explore the stacked reservoir targets within the Souris, Red River, and Dry Creek intervals, where historical drilling has shown helium flow rates of up to 1.3% a…
…
continue reading
1
Arizona Gold & Silver launches 40 hole drill program at Philadelphia project
3:26
3:26
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:26
Arizona Gold and Silver CEO Mike Stark joined Steve Darling from Proactive to share an exciting update on the company's Philadelphia Project, where they’ve commenced a 40-hole drill program aimed at confirming high-grade mineralization. The exploration is split between two main drilling pads, with up to 20 holes planned per pad. Stark highlighted t…
…
continue reading
Why Jennifer Warren has been focusing on AI, data centers and energy demand (1:10). Shale, M&A and growth (5:00). Looking through lower oil prices; who's most affected? (11:00) Returns for Microsoft, Amazon, Meta, Digital Realty and SMH, the Semiconductor ETF, across 10 years (20:20). Portfolio theory testing; nuclear plays will take time (28:00). …
…
continue reading
1
FireFly Metals expands Green Bay copper-gold resource by 42%
2:17
2:17
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
2:17
FireFly Metals Ltd (ASX:FFM) managing director Steve Parson sits down with Proactive’s Tylah Tully to discuss a 42% increase in the mineral resource estimate (MRE) for its Green Bay Copper-Gold Project in Newfoundland, Canada, following an extensive 2023-2024 drilling program.The MRE now stands at 59 million tonnes at 2% copper equivalent (CuEq), r…
…
continue reading
1
Tryptamine Therapeutics raises $6 million to accelerate development of TRP-8803
4:25
4:25
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:25
Tryptamine Therapeutics Ltd (ASX: TYP) CEO Jason Carroll joins Proactive’s Tylah Tully to talk through $6 million the company has secured through a strategic placement of 300 million new shares at $0.02 each.The placement was supported by new and existing stakeholders, including cornerstone investors, the Merchant Biotech Fund and Dr Daniel Tillett…
…
continue reading
1
Orion Minerals advances Prieska and Okiep feasibility studies
10:59
10:59
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
10:59
Orion Minerals Ltd (ASX: ORN, JSE:ORN) managing director and CEO Errol Smart joins Proactive’s Tylah Tully to discuss progress on feasibility studies for the Prieska Copper-Zinc Mine (PCZM) and Okiep Copper Project (OCP) in South Africa’s Northern Cape.This comes as the company appointed Nick Fouche as PCZM project director and LMMS Consultants for…
…
continue reading
1
Bit Digital Inc. expands into tier 3 data centers with 46 million dollars Enovum acquisition
4:55
4:55
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:55
Bit Digital CEO Sam Tabar joined Steve Darling from Proactive to discuss the company’s acquisition of Enovum Data Centers, a high-performance computing (HPC) datacenter operator, for approximately CAD $62.8 million (USD $46M). This acquisition represents a vertical integration of Bit Digital's HPC business, bringing a fully operational Tier 3 datac…
…
continue reading
1
Tonix Pharmaceuticals CEO Discusses New Drug Application for Fibromyalgia Treatment
5:17
5:17
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:17
Dr. Seth Lederman, CEO of Tonix Pharmaceuticals joined Steve Darling from Proactive to share news about the company's submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for its drug TNX-102 SL, a non-opioid analgesic designed to treat chronic pain associated with fibromyalgia. TNX-102 SL demonstrated statistically s…
…
continue reading
1
Ocean Power Technologies Advances Autonomous Maritime Technology in U.S. Navy Project Overmatch
5:18
5:18
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:18
Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to share updates on OPT's recent completion of the second set of exercises as part of Project Overmatch, under a follow-on contract as a subcontractor to EpiSci. During these exercises, OPT deployed multiple WAM-V autonomous surface vehicles (ASVs) in the Mission Aut…
…
continue reading
1
Ondo InsurTech Boosts LeakBot Production to Meet Rising U.S. Demand Amid Expanding Partnerships
4:42
4:42
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:42
Ondo InsurTech PLC CEO Craig Foster joined Steve Darling from Proactive to share news the company has has ramped up production capacity for its LeakBot devices at its UK contract manufacturing facility in response to surging demand, especially in the U.S. market. LeakBot, the company’s signature claims-prevention technology for home insurers, addre…
…
continue reading
1
VettaFi's Stacey Morris Highlights Midstream Energy Sector’s Strong 2024 Performance and Stability
4:42
4:42
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:42
VettaFi Head of Energy Research Stacey Morris joined Steve Darling from Proactive to about about the resilience of the midstream energy sector in 2024, which has delivered strong results despite broader energy sector challenges. Unlike other energy segments, midstream companies focus on transporting energy via long-term, fee-based contracts, offeri…
…
continue reading
1
Shield Therapeutics Eyes Cash Flow Positive Target by 2025
6:32
6:32
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
6:32
Shield Therapeutics CEO Anders Lundstrom and CFO Santosh Shanbhag joined Steve Darling from Proactice to share its released an unaudited Q3 2024 trading update revealing $7.2 million in net revenues from ACCRUFeR prescriptions, with an average net selling price of $167 per prescription. Excluding July's summer buying trends, the NSP averaged $192 i…
…
continue reading
1
European Green Transition Confirms District-Scale Rare Earth Element Potential at Olserum Project
3:38
3:38
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:38
European Green Transition CEO Aiden Lavelle joined Steve Darling from Proactive to share promising early results from the company’s 13-hole drill program at the Olserum Rare Earth Element (REE) Project in Sweden. This initial phase of drilling, focused on de-risking the project, has validated Olserum’s potential as a district-scale REE asset, bring…
…
continue reading
1
The Pharma and Biotech Daily Podcast: Breaking Down the Latest Industry Acquisitions and Promising Therapies
1:08
1:08
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:08
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AbbVie has acquired Aliada Therapeutics for $1.4 billion, gaining access to a phase I anti-amyloid antibody and a novel platform for efficient blood-brain barrier transport. Meanwhile, the FDA's accelerated approval progr…
…
continue reading
1
HeraMED completes $3.1 million capital raise for HeraCARE expansion
11:56
11:56
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
11:56
HeraMED Ltd (ASX: HMD) managing director and CEO Anoushka Gungadin joins Proactive’s Tylah Tully after the company raised $3.1 million in a two-tranche placement targeting sophisticated and professional investors.Priced at 1.7 cents per share, the placement represents a 19% discount to the company’s 15-day volume-weighted average price (VWAP) of 2.…
…
continue reading
1
Element 25 upgrades Butcherbird resource estimate
3:22
3:22
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:22
Element 25 Limited (ASX: E25; OTCQX: ELMTF) managing director Justin Brown joins Proactive’s Tylah Tully to discuss the company’s revised mineral resource estimate (MRE) for the Butcherbird Manganese Project in the Pilbara region of Western Australia.Following a recent infill drilling program, the measured and indicated resources at the project hav…
…
continue reading
1
CuFe in alliance with Emmerson Resources and Tennant Minerals for Tennant Creek region development
4:00
4:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:00
CuFe Ltd (ASX:CUF) executive director Mark Hancock sits down with Proactive’s Tylah Tully to discuss a strategic alliance the company has entered with Emmerson Resources Ltd and Tennant Minerals Ltd, to explore copper, gold and critical metals opportunities in the Tennant Creek region of the Northern Territory.The alliance will assess the feasibili…
…
continue reading
1
Asian Battery Metals hits high-grade copper-nickel at Oval discovery; share price surges
3:54
3:54
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:54
Asian Battery Metals PLC (ASX: AZ9) managing director Gan-Ochir Zunduisuren sits down with Proactive’s Tylah Tully to discuss high-grade copper-nickel results the company has received from its Oval copper-nickel-PGE prospect in Mongolia’s Gobi-Altai region.Drilling in hole OVD021 yielded an intercept of 8.8 metres at 6.08% copper, 3.19% nickel, 1.6…
…
continue reading
1
Trust Stamp Launches Biometric Secure Module Project with Contactless Palm Authentication
3:25
3:25
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:25
Trust Stamp Senior Vice President of Research and Development at Reuben Farrugia joined Steve Darling from Proactive to announce the launch the company's latest initiative aimed at expanding its biometric cryptosystem, Stable IT2, to include contactless palm authentication. The new Biometric Secure Module (BSM) project will integrate both face and …
…
continue reading
1
Toggle3D.ai launches photo studio API, bringing advanced ai-powered image editing to businesses
4:58
4:58
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:58
Toggle3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce the launch of the company’s new Photo Studio API, designed to address the rising demand for scalable, high-quality photo editing across various industries. This API allows users to integrate Toggle3D.ai's advanced AI-driven image processing technology directly into thei…
…
continue reading
1
Discover Turbine’s way to build avatars true to patient biology [Sponsored]
18:15
18:15
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
18:15
Discover how Turbine Simulated Cell Technologies is transforming drug development by addressing biases in training data. Guests Bence Szalai, MD, PhD, and Istvan Taisz, MD, PhD, share insights on the challenges of biased AI models in biology and introduce their groundbreaking framework, EFFECT (Evaluation Framework for Predicting Efficacy of Cancer…
…
continue reading
1
Just the Facts: Riversgold visits Saint John Project; plans drone survey
1:29
1:29
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:29
Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Riversgold Ltd (ASX:RGL).The company recently completed a site visit to its Saint John Project, a high-grade copper, gold, antimony and silver property in New Brunswick, Canada.During the visit, the team collected 64 rock chip samples from established and new mineralisatio…
…
continue reading
1
Pharma and Biotech Daily: Sanofi's Success, CRISPR Breakthroughs, and Industry Updates
1:16
1:16
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:16
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world.Sanofi beat third-quarter forecasts with a 381% growth in sales of its newly launched respiratory syncytial virus antibody, Beyfortus, bringing in almost $700 million. Analysts expect similar sales in the fourth quarter. …
…
continue reading
1
Just the Facts: Maximus Resources completes RC drilling
1:16
1:16
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:16
Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Maximus Resources Ltd (ASX:MXR, OTC:MXRRF).The company has completed reverse circulation (RC) drilling across two key projects in Western Australia's Goldfields region.The first-phase RC drilling at the 8500N Paleochannel, consisting of 102 holes, aimed to improve geologic…
…
continue reading
1
Sarytogan Graphite expands market reach - new uses for Micro80C in cast iron
6:34
6:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
6:34
Sarytogan Graphite Ltd managing director Sean Gregory joins Jonathan Jackson in the Proactive studio after the company identified significant market potential for its Micro80C graphite product, targeting the grey cast iron industry as a potential high-volume application for its recarburiser.Testing has shown that this product is effective in reintr…
…
continue reading
1
Excite Technology Services strengthens cyber security offering with CBIT acquisition
5:06
5:06
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:06
Excite Technology Services Ltd (ASX:EXT) executive director and CFO Steven Bliim talked with Proactive’s Tylah Tully about the company’s positioning as a unique cyber security provider on the ASX, with a current market capitalisation of $20 million.Bliim outlined the company’s main business segments, including cyber consulting, IT managed services …
…
continue reading
1
Dynamic Metals advances key assets during September quarter, maintains strong cash position
4:12
4:12
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:12
Dynamic Metals Ltd (ASX:DYM) managing director and CEO Karen Wellman joins Proactive’s Tylah Tully to talk about exciting developments at the Cognac West Prospect and the company’s broader exploration strategy in Western Australia.She revealed that recent rock chip sampling at Cognac West returned results as high as 2040 grams per tonne, or 65 ounc…
…
continue reading
1
Wishpond Announces Collaboration with Roomvu to Enhance Lead Management for Real Estate Agents
5:03
5:03
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:03
Wishpond CEO Ali Tajskandar joined Steve Darling from Proactive to share news of a collaboration between SalesCloser.ai and Roomvu Technologies, a leading real estate marketing platform used by over 220,000 agents. This partnership aims to enhance lead follow-up and sales conversion by integrating SalesCloser’s advanced technology into Roomvu’s pla…
…
continue reading
EY recently published their 18th annual Pulse of the MedTech Industry report, highlighting how—despite steadily rising profits year-over-year—devicemakers large and small are still being squeezed by the cost of doing business and waning investor enthusiasm. During AdvaMed’s MedTech Conference this month in Toronto, John Babbitt, partner on the life…
…
continue reading
1
Pharma and Biotech Daily: Novo Nordisk's Semaglutide Shows Promise in Alzheimer's Prevention, Roche's Billion Dollar Gene Therapy Deal, Off-Label GLP-1 Use on the Rise
1:01
1:01
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:01
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A study has found that Novo Nordisk's semaglutide may reduce the risk of Alzheimer's disease by 40% to 70%. Roche has entered a potential $1 billion gene therapy deal with Dyno Therapeutics, focusing on neurological diseas…
…
continue reading
1
Reward Minerals raises $2.3 million for Beyondie Potash Plant acquisition
5:11
5:11
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:11
Reward Minerals Ltd (ASX:RWD) CEO Lorry Hughes joins Proactive’s Tylah Tully to discuss the company’s efforts to raise $2.3 million through a share placement, selling over 38 million shares at $0.06 each, including one free attaching option per share.The funds will be used for an engineering scoping study focused on a sulphate of potash (SOP) proje…
…
continue reading
1
Horizon and Poseidon to merge, creating new mid-cap gold producer
4:02
4:02
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:02
Horizon Minerals (ASX:HRZ) managing director Grant Haywood joins Proactive’s Tylah Tully to discuss the company’s plans to merge with Poseidon Nickel Limited (ASX: POS).Horizon will acquire 100% of Poseidon's shares and unlisted options, subject to various conditions.This merger aims to consolidate their complementary assets in the Western Australi…
…
continue reading
1
Empire Metals completes Pitfield diamond drilling, advances MRE
5:00
5:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:00
Empire Metals Ltd (LON:EEE) managing director Shaun Bunn sits down with Proactive’s Tylah Tully to discuss the recently completed diamond drilling programme at the Pitfield Project in Western Australia.This phase focused on the Thomas and Cosgrove exploration target areas, with a total of 679 metres drilled across five holes.The drilling identified…
…
continue reading
1
Suvo Strategic Minerals raises $2 million with PERMAcast support
8:22
8:22
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
8:22
Suvo Strategic Minerals Ltd (ASX:SUV) executive chairman Aaron Banks joins Proactive’s Tylah Tully to discuss the $2 million the company secured through an oversubscribed placement at $0.048 per share, supporting its development and commercialisation of low-carbon cement Intellectual Property (IP).In further news, Suvo’s subsidiary Climate Tech Cem…
…
continue reading
1
Novo Resources makes strong progress in Western Australia and Victoria
5:01
5:01
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:01
Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) executive co-chairman and acting CEO Mike Spreadborough joins Proactive’s Tylah Tully to discuss the company’s September quarterly, which proved productive with significant exploration progress in Western Australia and Victoria.The company is in a strong financial position, holding A$6.7 million i…
…
continue reading
1
TRX Gold Reports Best-Ever Drill Result and New Discovery at Buckreef Gold Project
3:22
3:22
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:22
TRX Gold Corporation CEO Stephen Mullowney joined Steve Darling from Proactive to announced the company's most impressive drill result to date, with hole BMDD310 intersecting 35.5 meters at 5.48 g/t gold (Au) from a depth of 64 meters. This result was obtained approximately 200 meters east of the Buckreef Main Zone, which is home to Buckreef Gold's…
…
continue reading
1
Bloomsbury Publishing seeing Strong Fiscal Year Following 32% Revenue Surge
14:12
14:12
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
14:12
Bloomsbury Publishing CEO Nigel Newton, Group Finance Director Penny Scott-Bayfield , and Jenny Rideout, Managing Director joined Steve Darling from Proactive to announce that its fiscal year 2024-2025 trading is set to surpass expectations after reporting a 32% increase in first-half revenue. The surge was driven largely by the continued blockbust…
…
continue reading
1
Enwave Corporation Signs Strategic Agreement with CNTA to Deploy REV Dehydration Technology
2:12
2:12
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
2:12
Brent Charleton, President and CEO of Enwave Corporation, shared with Steve Darling from Proactive that the company has entered into a license agreement, equipment purchase agreement, and referral agreement with the Spanish National Centre for Food Technology and Safety (CNTA). CNTA is a private non-profit organization dedicated to enhancing the co…
…
continue reading
